InvestorsObserver is giving Idera Pharmaceuticals Inc (IDRA) an Analyst Rating Rank of 80, meaning IDRA is ranked higher by analysts than 80% of stocks. The average projection by analysts for IDRA is $7 over the next 12 months and analyst’s classify the stock as a Strong Buy
Why are Analyst Ratings Important?
Though analyst projections should not be your only resource when determining your position on a stock, it can be a very useful tool. Analysts follow sectors/industries in-depth and tend to know how local and global conditions tend to affect demand and prices. Many analysts even participate in conference calls where they can get information to better make sense of the numbers.
InvestorsObserver averages the ratings provided by analysts and then ranks their score as a percent against the market. This allows you to compare stocks in a more comprehensive fashion than with the typical buy/sell/hold ranking.
What's Happening With Idera Pharmaceuticals Inc Stock Today?
Idera Pharmaceuticals Inc (IDRA) stock is trading at $2.28 as of 3:20 PM on Tuesday, Sep 15, a gain of $0.27, or 13.43% from the previous closing price of $2.01. The stock has traded between $2.07 and $2.39 so far today. Volume today is above average. So far 468,590 shares have traded compared to average volume of 243,547 shares.
Click Here to get the full report on Idera Pharmaceuticals Inc (IDRA) Stock.
